Skip to main content

KBC Group NV

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 1411133 Brussels, C9

Position in ALNY

as of Mar 31, 2026 · filed May 7, 2026
Position Value
$6,790,774
-$131,668,568 QoQ
Shares Held
20,524
-94.1% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Common Shares in ALNY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

KBC Group NV holds $172,610,851 across 111 Biotechnology names. ALNY ranks #6 (3.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 ALNY
Alnylam Pharmaceuticals, Inc.
This page
20,524 $6,790,774

All Filings in ALNY

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $6,790,774 20,524
2025-12-31 $138,459,342 348,194
2025-09-30 $124,648,512 273,352
2025-06-30 $63,114,719 193,550
2025-03-31 $5,214,625 19,312
2024-12-31 $7,065,417 30,026
2024-09-30 $6,756,386 24,566
2024-06-30 $3,668,328 15,096
2024-03-31 $2,256,096 15,096
2023-12-31 $2,662,321 13,909
2023-09-30 $2,746,820 15,510
2023-06-30 $2,681,952 14,120
2023-03-31 $5,610,161 28,006
2022-12-31 $1,515,494 6,377
2022-09-30 $1,566,452 7,826
2022-06-30 $1,116,335 7,654
2022-03-31 $1,214,714 7,439
2021-12-31 $1,227,589 7,239
2021-09-30 $2,803,639 14,849
2021-06-30 $2,377,009 14,022
2021-03-31 $1,351,047 9,569
2020-12-31 $1,243,682 9,569
2020-09-30 $1,393,246 9,569
2020-06-30 $3,662,464 24,728
2020-03-31 $1,422,560 13,069